← Open Payments lookup

JENNIFER JABLONSKI: Open Payments

NPI 1336603976 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,184 in 39 payments from 11 companies in 2025. Trend: 2023 $428 · 2024 $489 · 2025 $1,184

Food & beverage: $1,184
CompanyPaymentsAmount
ViiV Healthcare Company18$752
ABBVIE INC.4$75
Insmed, Inc.4$73
Astellas Pharma US Inc3$67
Theratechnologies Inc.2$47
Grifols USA, LLC2$47
Paratek Pharmaceuticals, Inc.2$31
Gilead Sciences, Inc.1$28
Aimmune Therapeutics, Inc.1$27
Merck Sharp & Dohme LLC1$18

Products named: CABENUVA, DOVATO, Arikayce, Cresemba, EGRIFTA, Gamunex-C, DALVANCE, TEFLARO.

Industry payments across TX — which companies pay providers there.